Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. Morbidity and Mortality Weekly Report
2013; 62: 165–170.
Siegel, JD, et al.
Management of multidrug-resistant organisms in health care settings, 2006. American Journal of Infection Control
2007; 35 (Suppl. 2): S165–193.
Boucher, HW, et al.
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Diseases
2009; 48: 1–12.
Hidron, AI, et al.
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control and Hospital Epidemiology
2008; 29: 996–1011.
Wisplinghoff, H, et al.
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases
2004; 39: 309–317.
Deshpande, LM, et al.
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagnostic Microbiology and Infectious Diseases
2007; 58: 163–170.
System NNIS. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control
2004; 32: 470–485.
Quale, J, et al.
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clinical Infectious Diseases
1996; 23: 1020–1025.
Bradley, SJ, et al.
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. Journal of Antimicrobial Chemotherapy
1999; 43: 261–266.
Montecalvo, MA, et al.
Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Annals of Internal Medicine
1999; 131: 269–272.
Smith, DW. Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy
1999; 19: 129S–132S; discussion 33S–37S.
Manzella, J, et al.
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia. Infection Control and Hospital Epidemiology
2000; 21: 789–791.
May, AK, et al.
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock
2000; 14: 259–264.
Nourse, C, et al.
Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiology and Infection
2000; 124: 53–59.
Puzniak, LA, et al.
Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clinical Infectious Diseases
2001; 33: 151–157.
Lautenbach, E, et al.
Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clinical Infectious Diseases
2003; 36: 440–446.
Stiefel, U, et al.
Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers. Infection Control and Hospital Epidemiology
2004; 25: 380–383.
Paterson, DL, et al.
Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens. Antimicrobial Agents and Chemotherapy
2008; 52: 465–469.
Donskey, CJ, et al.
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. New England Journal of Medicine
2000; 343: 1925–1932.
Donskey, CJ, et al.
Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infection Ccontrol and Hospital Epidemiology
2002; 23: 436–440.
Donskey, CJ, et al.
Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Journal of Infectious Diseases
1999; 180: 384–390.
Lakticova, V, et al.
Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora. Antimicrobial Agents and Chemotherapy
2006; 50: 3117–3123.
Rice, LB, et al.
Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. Journal of Infectious Diseases
2004; 189: 1113–1118.
Taur, Y, et al.
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clinical Infectious Diseases
2012; 55: 905–14.
Bonten, MJ, et al.
The role of ‘colonization pressure’ in the spread of vancomycin-resistant enterococci: an important infection control variable. Archives of Internal Medicine
1998; 158: 1127–1132.
McKinnell, JA, et al.
Association between vancomycin-resistant enterococci bacteremia and ceftriaxone usage. Infection Control and Hospital Epidemiology
2012; 33: 718–724.
Weinstein, JW, et al.
Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. Journal of Clinical Microbiology
1996; 34: 210–212.
Donskey, CJ, et al.
Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Journal of Infectious Diseases
2000; 181: 1830–1833.
Bhalla, A, et al.
Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infection Control and Hospital Epidemiology
2003; 24: 644–649.
Kinnebrew, MA, et al.
Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. Journal of Infectious Diseases
2010; 201: 534–543.
Poutanen, SM, Simor, AE.
Clostridium difficile-associated diarrhea in adults. Canadian Medical Association Journal
2004; 171: 51–58.
Kyne, L, et al.
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet
2001; 357: 189–193.